Guy Sauvageau
Montreal, QC, Canada
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 122 publications
A Chemical-Genetic Interaction Matrix Reveals Drug Mechanism and Genetic Architecture.
Journal: bioRxiv : the preprint server for biology
Published: February 09, 2026
Risk factors for EBV reactivation and impact of graft composition following GVHD prophylaxis with rabbit ATG or PTCy.
Journal: Bone marrow transplantation
Published: January 21, 2026
Rapidly Expanded EBV-Specific T Cells for the Treatment of Refractory EBV Reactivation and EBV-Related Lymphoproliferative Disorders.
Journal: Open forum infectious diseases
Published: December 23, 2025
Comparison of Outcomes after UM171-Expanded Cord Blood and Six Conventional Donor Source Transplants: A Matched Analysis from the EBMT Registry.
Journal: Transplantation and cellular therapy
Published: June 10, 2025
CoREST in pieces: Dismantling the CoREST complex for cancer therapy and beyond.
Journal: Science advances
Published: June 06, 2025
High IL1R1 expression predicts poor survival and benefit from stem cell transplant in intermediate-risk acute myeloid leukemia from the Leucegene cohort.
Journal: Biomarker research
Published: May 15, 2025
CD33 epitope editing unlocks UM171-expanded cord blood grafts for AML immunotherapy.
Journal: Molecular therapy : the journal of the American Society of Gene Therapy
Published: April 24, 2025
Allogeneic Hematopoietic Cell Transplant for B-Cell Lymphomas in the Era of Novel Cellular Therapies: Experience from a Tertiary Canadian Center.
Journal: Current oncology (Toronto, Ont.)
Published: March 24, 2025
IL1RAP is an immunotherapeutic target for normal karyotype triple-mutated acute myeloid leukemia.
Journal: Biomarker research
Published: November 06, 2024
Last Updated: 09/26/2026